Lab-Grown Brain Tumor Models Test an Omega-3-Derived Compound’s Effects on Cancer and Healthy Brain Cells
Researchers built a new lab model called a ‘brain assembloid’ by combining human brain cancer cells (high-grade glioma) with lab-grown mini brain tissue (organoids) made from stem cells. This let them study how a treatment behaves near both cancerous and healthy brain cells at the same time, rather than testing cancer cells alone.
The compound tested, called PTU, is a lab-made version of a molecule derived from omega-3 fatty acids. In simpler cancer-cell-only experiments, PTU blocked a protein called cofilin that cancer cells use to invade surrounding tissue, causing the cells to round up and stop spreading through a gel matrix.
However, when tested in the more realistic assembloid model that included healthy brain tissue, the results were mixed and depended on which cancer cell line was used. Detailed imaging showed that PTU also affected signaling pathways in the healthy brain organoid tissue, not just the cancer cells, raising questions about unintended side effects.
What this means for you
This is early-stage laboratory research using engineered cell models, not a human clinical trial, so it doesn’t tell us anything about taking omega-3 supplements for cancer prevention or treatment. Its main value is demonstrating a new lab method for checking whether cancer-fighting compounds might also harm healthy brain tissue before they are ever tested in people.
Ready to start? The ALP Protocol delivers the EPA & DHA doses used in the research.
Start the ALP ProtocolThis summary is for educational purposes only and is not medical advice. Always talk to your healthcare provider before making changes to your supplement routine.